| Ticker | Company | Zen Rating | Sentiment | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
|---|---|---|---|---|---|---|---|---|---|
| ALNY | ALNYLAM PHARMACEUTICALS INC | A | C | $60.52B | 132,113,818 | 82.79% | 17.21% | Net Selling | Net Selling |
| CALX | CALIX INC | A | A | $3.59B | 66,276,473 | 77.48% | 22.52% | Net Selling | Net Selling |
| MYRG | MYR GROUP INC | A | C | $3.55B | 15,522,834 | 71.01% | 28.99% | Net Selling | Net Selling |
| AORT | ARTIVION INC | A | B | $2.11B | 47,374,939 | 80.10% | 19.90% | Net Selling | Net Selling |
| APPN | APPIAN CORP | A | B | $3.02B | 73,823,168 | 46.57% | 53.43% | Net Selling | Net Selling |
| ARLO | ARLO TECHNOLOGIES INC | A | C | $1.54B | 105,992,268 | 96.42% | 3.58% | Net Selling | Net Selling |
| INNV | INNOVAGE HOLDING CORP | A | C | $682.48M | 135,681,431 | 4.58% | 95.42% | Net Selling | Net Selling |
| OPFI | OPPFI INC | A | B | $873.13M | 86,362,551 | 9.43% | 90.57% | Net Selling | Net Selling |
| VREX | VAREX IMAGING CORP | A | B | $482.89M | 41,700,000 | 93.34% | 1.63% | Net Selling | Net Selling |
| EHAB | ENHABIT INC | A | A | $472.16M | 50,607,075 | 96.08% | 3.92% | Net Buying | Net Buying |
| SHC | SOTERA HEALTH CO | A | B | $4.76B | 284,093,929 | 80.03% | 19.97% | Net Selling | Net Selling |
| ORGO | ORGANOGENESIS HOLDINGS INC | A | A | $601.56M | 126,912,142 | 6.93% | 93.07% | Net Selling | Net Selling |
| COMM | COMMSCOPE HOLDING COMPANY INC | A | B | $4.25B | 221,548,707 | 88.34% | 8.08% | Net Selling | |
| TENB | TENABLE HOLDINGS INC | A | B | $3.15B | 119,344,266 | 67.66% | 32.34% | Net Selling | Net Selling |
| AUGO | AURA MINERALS INC | A | C | $3.44B | 83,534,506 | 10.43% | 0.00% | ||
| CAH | CARDINAL HEALTH INC | A | B | $47.24B | 237,595,042 | 86.48% | 4.15% | Net Selling | Net Selling |
| TG | TREDEGAR CORP | A | C | $263.58M | 34,910,693 | 62.25% | 21.75% | Net Selling | Net Selling |
| BCRX | BIOCRYST PHARMACEUTICALS INC | A | C | $1.60B | 210,543,224 | 83.90% | 16.10% | Net Selling | Net Selling |
| ONC | BEONE MEDICINES LTD | A | A | $35.77B | 1,438,553,263 | 2.29% | 32.11% | Net Buying | Net Selling |
| CRNC | CERENCE INC | A | B | $568.03M | 44,938,757 | 18.72% | 81.28% | Net Buying | Net Buying |
| MIRM | MIRUM PHARMACEUTICALS INC | A | C | $3.52B | 51,393,574 | 52.35% | 47.65% | Net Selling | Net Buying |
| AENT | ALLIANCE ENTERTAINMENT HOLDING CORP | A | A | $747.85M | 110,957,370 | 0.65% | 35.44% | Net Buying | |
| OESX | ORION ENERGY SYSTEMS INC | A | A | $57.98M | 3,530,870 | 7.02% | 92.98% | Net Buying | Net Buying |
| CSTM | CONSTELLIUM SE | A | B | $2.45B | 137,801,779 | 93.26% | 0.00% | ||
| NVT | NVENT ELECTRIC PLC | A | B | $17.38B | 161,359,550 | 90.40% | 9.60% | Net Selling | Net Buying |
| ALNT | ALLIENT INC | A | B | $923.59M | 16,943,497 | 71.13% | 28.87% | Net Buying | Net Selling |
| NATR | NATURES SUNSHINE PRODUCTS INC | A | A | $382.80M | 17,495,563 | 22.14% | 77.86% | Net Selling | Net Buying |
| HAS | HASBRO INC | A | C | $11.38B | 140,337,023 | 54.21% | 45.79% | Net Selling | Net Selling |
| ELAN | ELANCO ANIMAL HEALTH INC | A | B | $10.88B | 496,863,473 | 91.70% | 8.30% | Net Selling | |
| ANIP | ANI PHARMACEUTICALS INC | A | C | $1.84B | 22,469,032 | 29.82% | 70.18% | Net Selling | Net Selling |
| VVX | V2X INC | A | C | $1.75B | 31,535,083 | 94.53% | 5.47% | Net Selling | Net Selling |
| BCO | BRINKS CO | A | C | $4.85B | 41,545,506 | 81.04% | 18.96% | Net Selling | Net Selling |
| MOG.A | MOOG INC | A | B | $7.52B | 31,676,836 | 87.63% | 3.91% | Net Selling | Net Selling |
| FRSH | FRESHWORKS INC | A | A | $3.62B | 281,971,753 | 71.51% | 13.27% | Net Selling | Net Buying |
| SPNT | SIRIUSPOINT LTD | A | A | $2.51B | 116,814,640 | 64.36% | 35.64% | Net Selling | Net Buying |
| ZUMZ | ZUMIEZ INC | A | A | $519.00M | 16,949,578 | 55.37% | 44.63% | Net Selling | Net Selling |
| RSI | RUSH STREET INTERACTIVE INC | A | B | $4.22B | 229,412,772 | 26.62% | 73.38% | Net Selling | Net Selling |
| FRD | FRIEDMAN INDUSTRIES INC | A | C | $138.83M | 7,112,182 | 53.21% | 15.55% | Net Buying | Net Buying |
| BSBR | BANCO SANTANDER (BRASIL) SA | A | C | $45.50B | 7,459,627,927 | 7.19% | 0.00% | ||
| NMRK | NEWMARK GROUP INC | A | C | $3.15B | 180,412,407 | 60.88% | 39.12% | Net Selling | Net Selling |
| RNG | RINGCENTRAL INC | A | C | $2.57B | 86,564,715 | 89.18% | 10.82% | Net Selling | Net Selling |
| YEXT | YEXT INC | A | C | $1.09B | 123,236,797 | 52.88% | 47.12% | Net Selling | Net Selling |
| HCI | HCI GROUP INC | A | A | $2.21B | 12,960,037 | 78.69% | 9.80% | Net Selling | |
| DLX | DELUXE CORP | A | C | $940.21M | 45,007,664 | 84.38% | 4.98% | Net Selling | Net Selling |
| EXTR | EXTREME NETWORKS INC | A | B | $2.35B | 133,718,479 | 82.39% | 17.61% | Net Selling | Net Selling |
| PCRX | PACIRA BIOSCIENCES INC | A | C | $1.03B | 43,021,275 | 67.54% | 32.46% | Net Selling | Net Selling |
| DOOO | BRP INC | A | A | $5.62B | 73,354,347 | 40.98% | 0.00% | ||
| PAHC | PHIBRO ANIMAL HEALTH CORP | A | C | $1.59B | 40,533,608 | 43.59% | 56.41% | Net Selling | Net Selling |
| CCLD | CARECLOUD INC | A | B | $131.85M | 42,397,039 | 20.97% | 5.62% | Net Selling | Net Selling |
| KALU | KAISER ALUMINUM CORP | A | A | $1.70B | 16,206,255 | 95.96% | 3.05% | Net Selling | Net Selling |
| MATV | MATIV HOLDINGS INC | A | A | $660.55M | 54,681,114 | 89.94% | 9.27% | Net Selling | Net Buying |
| CMC | COMMERCIAL METALS CO | A | C | $7.42B | 110,968,083 | 91.14% | 8.86% | Net Selling | Net Selling |
| CMRC | COMMERCECOM INC | A | B | $377.06M | 81,263,346 | 65.85% | 34.15% | Net Selling | Net Selling |
| DINO | HF SINCLAIR CORP | A | B | $9.21B | 183,948,233 | 61.43% | 38.57% | Net Selling | Net Selling |
| CYD | CHINA YUCHAI INTERNATIONAL LTD | A | B | $1.30B | 37,518,322 | 18.38% | 0.00% | ||
| JBL | JABIL INC | A | B | $23.51B | 106,837,337 | 61.25% | 38.75% | Net Selling | Net Selling |
| MDXG | MIMEDX GROUP INC | A | B | $1.03B | 148,102,159 | 46.43% | 53.57% | Net Buying | Net Selling |
| IMAX | IMAX CORP | A | C | $1.92B | 53,798,934 | 60.90% | 39.10% | Net Selling | Net Selling |
| RAMP | LIVERAMP HOLDINGS INC | A | B | $1.87B | 63,648,844 | 54.92% | 45.08% | Net Selling | Net Selling |
| RERE | ATRENEW INC | A | A | $571.63M | 161,397,323 | 32.50% | 0.00% | ||
| NVST | ENVISTA HOLDINGS CORP | A | C | $3.33B | 164,426,233 | 63.77% | 36.23% | Net Selling | Net Selling |
| FOLD | AMICUS THERAPEUTICS INC | A | A | $3.05B | 308,533,548 | 65.98% | 34.02% | Net Selling | Net Selling |
| INDV | INDIVIOR PLC | A | A | $4.38B | 124,853,897 | 100.00% | 0.00% | ||
| HCSG | HEALTHCARE SERVICES GROUP INC | A | C | $1.33B | 70,455,509 | 95.26% | 4.74% | Net Selling | Net Selling |
| STRT | STRATTEC SECURITY CORP | A | B | $329.80M | 4,185,271 | 78.78% | 19.62% | Net Selling | Net Buying |
| DBD | DIEBOLD NIXDORF INC | A | B | $2.34B | 35,867,156 | 83.20% | 16.80% | Net Selling | Net Selling |
| OOMA | OOMA INC | A | B | $324.02M | 27,600,000 | 69.63% | 24.92% | Net Selling | Net Selling |
| AVAH | AVEANNA HEALTHCARE HOLDINGS INC | A | A | $1.94B | 208,911,383 | 24.81% | 75.19% | Net Selling | Net Selling |
| MCFT | MASTERCRAFT BOAT HOLDINGS INC | A | C | $295.15M | 16,288,798 | 39.33% | 60.67% | Net Buying | Net Selling |
| MG | MISTRAS GROUP INC | A | C | $363.75M | 31,548,153 | 50.45% | 37.10% | Net Buying | Net Buying |
| FIVN | FIVE9 INC | A | C | $1.62B | 78,216,052 | 71.46% | 28.54% | Net Selling | Net Selling |
| TXT | TEXTRON INC | A | C | $14.71B | 176,224,064 | 86.91% | 1.67% | Net Selling | |
| TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | A | C | $32.65B | 1,147,282,512 | 57.27% | 0.76% | Net Selling | Net Selling |
| TBLA | TABOOLACOM LTD | A | A | $1.14B | 288,223,366 | 29.76% | 28.29% | Net Selling | Net Selling |
| CMCO | COLUMBUS MCKINNON CORP | A | B | $492.69M | 28,728,261 | 61.76% | 38.24% | Net Buying | |
| APTV | APTIV PLC | A | B | $16.50B | 216,079,411 | 80.25% | 19.75% | Net Selling | Net Selling |
| SEB | SEABOARD CORP | A | C | $4.22B | 957,951 | 5.94% | 94.06% | ||
| BGC | BGC GROUP INC | A | B | $4.12B | 468,747,805 | 40.35% | 59.65% | Net Buying | Net Buying |
| ANAB | ANAPTYSBIO INC | A | A | $1.23B | 27,688,470 | 42.69% | 57.31% | Net Buying | Net Selling |
| KN | KNOWLES CORP | A | C | $1.99B | 85,151,884 | 96.62% | 3.38% | Net Selling | Net Selling |
| COLL | COLLEGIUM PHARMACEUTICAL INC | A | C | $1.51B | 31,610,976 | 51.95% | 48.05% | Net Selling | Net Selling |
| SNDK | SANDISK CORP | A | A | $33.48B | 146,553,179 | 84.96% | 5.73% | Net Selling | Net Selling |
| PRLB | PROTO LABS INC | A | B | $1.23B | 23,678,745 | 65.78% | 34.22% | Net Selling | Net Buying |
| ORLA | ORLA MINING LTD | A | C | $4.19B | 337,560,000 | 61.93% | 0.00% | ||
| VTEX | VTEX | A | B | $707.84M | 181,963,227 | 38.42% | 0.00% | ||
| AMRX | AMNEAL PHARMACEUTICALS INC | A | A | $3.83B | 314,362,920 | 28.65% | 71.35% | Net Selling | Net Selling |
| TRX | TRX GOLD CORP | A | C | $230.45M | 284,861,895 | 2.47% | 3.40% | ||
| DY | DYCOM INDUSTRIES INC | A | B | $10.19B | 28,956,051 | 94.01% | 5.99% | Net Selling | Net Selling |
| TBRG | TRUBRIDGE INC | A | B | $345.51M | 15,008,986 | 31.00% | 69.00% | Net Buying | Net Buying |
| CION | CION INVESTMENT CORP | A | B | $513.61M | 51,670,947 | 37.01% | 0.84% | Net Buying | |
| MGA | MAGNA INTERNATIONAL INC | A | B | $13.82B | 281,814,257 | 65.04% | 0.00% | ||
| EWCZ | EUROPEAN WAX CENTER INC | A | B | $220.16M | 54,360,321 | 36.55% | 63.45% | Net Selling | |
| LTM | LATAM AIRLINES GROUP SA | A | B | $30.72B | 604,437,877,587 | 0.01% | 0.00% | ||
| HII | HUNTINGTON INGALLS INDUSTRIES INC | A | C | $11.95B | 39,241,434 | 94.06% | 4.23% | Net Buying | Net Selling |
| FCFS | FIRSTCASH HOLDINGS INC | A | B | $6.79B | 44,134,150 | 80.41% | 19.59% | Net Selling | Net Selling |
| PRIM | PRIMORIS SERVICES CORP | A | B | $6.79B | 54,032,351 | 77.12% | 22.88% | Net Selling | Net Selling |
| VRT | VERTIV HOLDINGS CO | A | B | $72.27B | 382,338,313 | 78.23% | 12.09% | Net Selling | Net Selling |
| EGHT | 8X8 INC | A | A | $281.44M | 138,640,363 | 70.01% | 29.99% | Net Selling | Net Selling |
| GNE | GENIE ENERGY LTD | A | C | $375.17M | 26,494,954 | 37.01% | 47.33% | Net Selling | Net Selling |
| VCYT | VERACYTE INC | A | B | $3.53B | 79,049,173 | 67.82% | 32.18% | Net Selling | Net Selling |
Use the proven Zen Ratings quant model to find stocks with high potential to beat the market. Stocks Zen-Rated "A" have beaten the market by +32.52% annually. Learn More
It’s little wonder that growth stocks have a reputation as exciting, high-reward investing opportunities. After all, some of the most successful stocks — think Amazon (NASDAQ: AMZN), Tesla (NASDAQ: TSLA), and Nvidia (NASDAQ: NVDA) — started as growth stocks.
However, not every stock experiencing rapid development will go on to dominate the stock market. The potential for high rewards comes with increased risk. A company showing high revenue growth doesn’t necessarily equal a great investment.
Keep reading to learn:
A growth stock is a company whose revenue, earnings, or market share is expanding at a significantly faster rate than the market average or its industry peers.
Companies that prioritize rapid revenue and earnings growth often reinvest profits instead of paying dividends, betting their money on expansion, innovation, and market dominance.
In the stock market, a security's success can last for minutes — or decades. How can you tell the difference between a stock that's portfolio-worthy for the long haul versus one fueled by temporary market hype?
True growth stocks typically have strong fundamentals, such as consistent revenue growth, expanding profit margins, and a competitive edge (for example, proprietary technology or brand dominance). They also have a scalable business model and demonstrate resilience across market cycles, such as during periods of high interest rates or other major economic events.
In contrast, stocks driven by temporary market trends — say, meme stocks or companies capitalizing on short-lived trends — often rely on speculative momentum but lack solid financials and struggle to sustain growth once the fad fades. The decline can happen fast — for instance, a company that was killing it in the fourth quarter could report a net loss by their next earnings report.
Here are some characteristics to look for before you buy:
Perhaps the biggest misconception in growth investing is that the best way to generate fast returns is to buy shares of the fastest-growing companies.
In reality, stocks with the highest projected growth rates tend to deliver the worst stock price performance. At first glance, this might seem like a strange concept, so let’s break it down.
When a company is expected to grow earnings by 30%+ per year, its stock experiences a surge in price, often experiencing a powerful period of price appreciation. But it is often unsustainable.
Why? Because the competition takes notice, adapts, and fights to gain market share. Maintaining that pace becomes nearly impossible.
Even if a company’s growth slows from 30% to a still-impressive 20%, it can be catastrophic for the stock if investors and analysts pricing it for higher expectations. The moment those investors and analysts realize the period of extreme growth is over, you can safely expect them to move on — and the stock price can collapse.
So, if you shouldn't buy solely based on rapid expansion and price action, what should you look for? Consistent, sustainable growth.
As for how to identify it…
Identifying stocks with growth potential requires a combination of research, analysis, and due diligence.
Our Best Stocks to Buy Now for High Growth screener can help you easily focus on stocks with a high Zen Rating for Growth.
As part of its overall 115-factor review of the 4600+ stocks we track, our quant model assesses 21 different measures of Growth. It considers sales and earnings growth, but it also looks for gains in revenue, cash flow, profit margins, and EBITDA to ensure that companies with strong or underrated growth prospects make the cut.
After all, the more consistent these gains, particularly across multiple growth measures, the more likely the stock's price will continue to appreciate.
However, that doesn’t tell the whole story. That’s why it’s important to take a big-picture view.
This may sound counterintuitive, but when looking for high-quality growth stocks to buy, it’s worth considering more than just growth, such as:
Zen Ratings can help you gain this type of bigger-picture view. In addition to reviewing 22 Growth Factors, it also zeroes in on 93 other Factors that can greatly increase the likelihood of outperforming the market, including 21 Value Factors, 26 Financial Factors, and more.
Locating the best growth stocks isn’t just about locating the most impressive price action in the market.
Our Best Growth Stocks to Buy Now screener can help you quickly locate stocks to buy, but it’s important to remember that growth doesn’t exist in a vacuum — you must consider the big picture.
Growth-oriented investors should seek stocks that display an overall A or B rating while also scoring A or B for Growth. However, you should also consider other factors that may support growth, such as Financials, Momentum, and Sentiment.
If you're looking for guidance in choosing high-quality stocks, consider becoming a Zen Investor member. The portfolio includes hand-picked stocks that have passed a rigorous screening process that considers criteria like valuation, performance, what analysts are saying, and more. Save time and energy — Gain access to the market-beating Zen Investor portfolio now.